Niagen Bioscience (NAGE) vs Tilray Brands (TLRY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Niagen Bioscience (NAGE) has outperformed Tilray Brands (TLRY) over the past year, losing 64.2% versus a loss of 79.1%. Over five years, NAGE leads with a -58.2% price change compared with -96.5% for TLRY. Tilray Brands is the larger company by market cap ($516.5 million vs $211.3 million), about 2.4 times the size.
On valuation, Tilray Brands trades at a lower forward P/E (7.9x vs 26.7x for Niagen Bioscience).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAGE | TLRY |
|---|---|---|
| Share price | $2.67 | $3.50 |
| Market cap | $211.27M | $516.50M |
| 1-day change | +0.38% | -2.64% |
| YTD return | -58.18% | -60.24% |
| 1-year return | -64.20% | -79.13% |
| 5-year return | -58.18% | -96.49% |
| P/E ratio (TTM) | 14.05 | — |
| Forward P/E | 26.70 | 7.94 |
| EPS (TTM) | $0.19 | $-1.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $20.20 |
| 52-week low | $2.61 | $3.38 |
| Distance from 52-week high | -66.42% | -82.70% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +352.43% | +104.86% |
| Average volume | 585.61K | 4.17M |
| Shares outstanding | 79.13M | 147.78M |
| Employees | 117 | 3,595 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Tilray Brands is about 2.4 times larger than Niagen Bioscience by market value ($516.50M vs $211.27M).
- NAGE has outperformed TLRY by 14.9 percentage points over the past year.
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
About Tilray Brands
TLRY stock →Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.
Health Care · Medicinal Chemicals and Botanical Products · 3,595 employees
NAGE vs TLRY FAQ
Which is bigger, Niagen Bioscience or Tilray Brands?
Tilray Brands (TLRY) is larger, with a market capitalization of $516.50M compared with $211.27M for Niagen Bioscience (NAGE).
Which stock has performed better over the past year, NAGE or TLRY?
NAGE returned -64.20% over the past 12 months, compared with -79.13% for TLRY (price return, excluding dividends). Past performance does not predict future results.
Are Niagen Bioscience and Tilray Brands in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.